HQL

abrdn Life Sciences Investors

86 hedge funds and large institutions have $135M invested in abrdn Life Sciences Investors in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$25.6M
SCM
2
Saba Capital Management
New York
$15.4M
PCM
3
Penserra Capital Management
California
$13.1M
Raymond James Financial
4
Raymond James Financial
Florida
$10.8M
LPL Financial
5
LPL Financial
California
$7.79M
NIM
6
Needham Investment Management
New York
$6.99M
FHA
7
Flagship Harbor Advisors
Massachusetts
$6.23M
Allspring Global Investments
8
Allspring Global Investments
North Carolina
$5.9M
RCM
9
Rivernorth Capital Management
Florida
$3.23M
Ameriprise
10
Ameriprise
Minnesota
$3.11M
FAM
11
Formidable Asset Management
Ohio
$2.66M
AAM
12
Advisors Asset Management
Colorado
$2.61M
1WA
13
180 Wealth Advisors
Washington
$2.43M
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1.97M
Bank of America
15
Bank of America
North Carolina
$1.88M
1CP
16
1607 Capital Partners
Virginia
$1.69M
Janney Montgomery Scott
17
Janney Montgomery Scott
Pennsylvania
$1.49M
WIA
18
World Investment Advisors
California
$1.48M
BBPWM
19
Blue Bell Private Wealth Management
Pennsylvania
$1.43M
UPS
20
UHLMANN PRICE SECURITIES
Illinois
$1.27M
PAG
21
Private Advisor Group
New Jersey
$1.25M
SFS
22
Shaker Financial Services
Virginia
$1.21M
ZCP
23
Z3 Capital Partners
Virginia
$1.1M
First Trust Advisors
24
First Trust Advisors
Illinois
$933K
SPIA
25
Steward Partners Investment Advisory
New York
$884K